デフォルト表紙
市場調査レポート
商品コード
1318920

ワクチンバイアルモニター市場:タイプ別(マルチ用量、単回用量)、用途別(予防ワクチン、治療ワクチン)-世界予測2023-2030年

Vaccine Vial Monitor Market by Type (Multi-Dose, Single Dose), Application (Preventive Vaccine, Therapeutic Vaccine) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ワクチンバイアルモニター市場:タイプ別(マルチ用量、単回用量)、用途別(予防ワクチン、治療ワクチン)-世界予測2023-2030年
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ワクチンバイアルモニターの世界市場は大きく成長すると予測され、2023年には2億2,425万米ドルが予測され、CAGRは22.87%、2030年には9億4,927万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のワクチンバイアルモニター市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.ワクチンバイアルモニターの世界市場規模および予測は?

2.予測期間中、世界のワクチンバイアルモニター市場を形成するCOVID-19の阻害要因と影響は?

3.ワクチンバイアルモニターの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.ワクチンバイアルモニターの世界市場における競争戦略は?

5.ワクチンバイアルモニターの世界市場における技術動向と規制の枠組みは?

6.ワクチンバイアルモニターの世界市場における主要ベンダーの市場シェアは?

7.ワクチンバイアルモニターの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ワクチン投与の需要と安全な使用の重要性
      • ワクチンバイアルの適切なモニタリングの必要性
      • 感染症の蔓延と予防接種を促進する取り組みの増加
    • 抑制要因
      • アプリケーションおよび物流に関連する問題
    • 機会
      • ワクチンバイアルモニターとコールドチェーンインフラの関係
      • 遠隔地における医療サービスの利用しやすさの向上に向けたヘルスケア分野の取り組みの強化
    • 課題
      • VVMに対する厳格な規制上の配慮
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 ワクチンバイアルモニター市場:タイプ別

  • 複数回投与
  • 単回投与

第7章 ワクチンバイアルモニター市場:用途別

  • 予防ワクチン
  • 治療用ワクチン

第8章 南北アメリカのワクチンバイアルモニター市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のワクチンバイアルモニター市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのワクチンバイアルモニター市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. VACCINE VIAL MONITOR MARKET RESEARCH PROCESS
  • FIGURE 2. VACCINE VIAL MONITOR MARKET SIZE, 2022 VS 2030
  • FIGURE 3. VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. VACCINE VIAL MONITOR MARKET DYNAMICS
  • FIGURE 8. VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. VACCINE VIAL MONITOR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. VACCINE VIAL MONITOR MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. VACCINE VIAL MONITOR MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. VACCINE VIAL MONITOR MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. ARGENTINA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. BRAZIL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. MEXICO VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AUSTRALIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CHINA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. INDIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. INDONESIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. JAPAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MALAYSIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. PHILIPPINES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. SINGAPORE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. SOUTH KOREA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. TAIWAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. THAILAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. VIETNAM VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. DENMARK VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EGYPT VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. FINLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. FRANCE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. GERMANY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ISRAEL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ITALY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. NETHERLANDS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. NIGERIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NORWAY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. POLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. QATAR VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. RUSSIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SAUDI ARABIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SPAIN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SWEDEN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SWITZERLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TURKEY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED ARAB EMIRATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED KINGDOM VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 97. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 98. VACCINE VIAL MONITOR MARKET LICENSE & PRICING
目次
Product Code: MRR-FB6C9E792F60

The Global Vaccine Vial Monitor Market is forecasted to grow significantly, with a projected USD 224.25 million in 2023 at a CAGR of 22.87% and expected to reach a staggering USD 949.27 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vaccine Vial Monitor Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vaccine Vial Monitor Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Multi-Dose and Single Dose. The Multi-Dose is projected to witness significant market share during forecast period.

Based on Application, market is studied across Preventive Vaccine and Therapeutic Vaccine. The Therapeutic Vaccine is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vaccine Vial Monitor Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vaccine Vial Monitor Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Vial Monitor Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Vial Monitor Market?

4. What is the competitive strategic window for opportunities in the Global Vaccine Vial Monitor Market?

5. What are the technology trends and regulatory frameworks in the Global Vaccine Vial Monitor Market?

6. What is the market share of the leading vendors in the Global Vaccine Vial Monitor Market?

7. What modes and strategic moves are considered suitable for entering the Global Vaccine Vial Monitor Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vaccine Vial Monitor Market, by Type, 2022 vs 2030
  • 4.3. Vaccine Vial Monitor Market, by Application, 2022 vs 2030
  • 4.4. Vaccine Vial Monitor Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Demand for administration and importance to the safe use of the vaccines
      • 5.1.1.2. Need for adequate monitoring of vaccine vials
      • 5.1.1.3. High prevalence of infectious diseases and a growing number of initiatives to promote immunization
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with applications, and logistics
    • 5.1.3. Opportunities
      • 5.1.3.1. Relationship between vaccine vial monitors and cold chain infrastructure
      • 5.1.3.2. Increasing healthcare sector efforts towards improving accessibility of medical services in remote areas
    • 5.1.4. Challenges
      • 5.1.4.1. Stingent regulatory consideration for VVM
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Vaccine Vial Monitor Market, by Type

  • 6.1. Introduction
  • 6.2. Multi-Dose
  • 6.3. Single Dose

7. Vaccine Vial Monitor Market, by Application

  • 7.1. Introduction
  • 7.2. Preventive Vaccine
  • 7.3. Therapeutic Vaccine

8. Americas Vaccine Vial Monitor Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vaccine Vial Monitor Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vaccine Vial Monitor Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing